Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Rasche

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patientsArtur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Haematologica|February 9, 2019
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patientsJohn R Jones, Niels Weinhold, Cody Ashby, et al.
Biomarker Research|May 16, 2023
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1Xiang Zhou, Seungbin Han, Nadine Cebulla, et al.
Blood|August 22, 2024
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myelomaMara John, Moutaz Helal, Johannes Duell, et al.
Leukemia|March 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myelomaJohannes Waldschmidt, David Fandrei, Judith S Hecker, et al.
American Journal of Hematology|June 18, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)Heinz Ludwig, Evangelos Terpos, Francesca Gay, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Blood Cancer Journal|November 1, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Nature Medicine|February 23, 2021
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myelomaMatteo C Da Vià, Oliver Dietrich, Marietta Truger, et al.
Blood Cancer Journal|July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patientsArtur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Haematologica|February 9, 2019
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patientsJohn R Jones, Niels Weinhold, Cody Ashby, et al.
Biomarker Research|May 16, 2023
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1Xiang Zhou, Seungbin Han, Nadine Cebulla, et al.
Blood|August 22, 2024
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myelomaMara John, Moutaz Helal, Johannes Duell, et al.
Leukemia|March 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myelomaJohannes Waldschmidt, David Fandrei, Judith S Hecker, et al.
American Journal of Hematology|June 18, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)Heinz Ludwig, Evangelos Terpos, Francesca Gay, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Blood Cancer Journal|November 1, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Nature Medicine|February 23, 2021
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myelomaMatteo C Da Vià, Oliver Dietrich, Marietta Truger, et al.
Blood Cancer Journal|July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvementMaximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Pageof 17